CN101843773B - Chinese medicament for treating liver cirrhosis - Google Patents

Chinese medicament for treating liver cirrhosis Download PDF

Info

Publication number
CN101843773B
CN101843773B CN2009102361821A CN200910236182A CN101843773B CN 101843773 B CN101843773 B CN 101843773B CN 2009102361821 A CN2009102361821 A CN 2009102361821A CN 200910236182 A CN200910236182 A CN 200910236182A CN 101843773 B CN101843773 B CN 101843773B
Authority
CN
China
Prior art keywords
chinese
chinese medicine
liver cirrhosis
radix
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102361821A
Other languages
Chinese (zh)
Other versions
CN101843773A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liu Xinzhuang
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102361821A priority Critical patent/CN101843773B/en
Publication of CN101843773A publication Critical patent/CN101843773A/en
Application granted granted Critical
Publication of CN101843773B publication Critical patent/CN101843773B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a Chinese medicament for treating liver cirrhosis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: fresh rehmannia root, Chinese wolfberry, lucid ganoderma, mix-fried turtle shell, radix pseudo-ginseng, Chinese angelica, cortex moutan and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, fostering yin and nourishing liver, and dissolving stasis and dispersing accumulations, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of liver cirrhosis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The Chinese medicine that is used for the treatment of liver cirrhosis at present, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of liver cirrhosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of liver cirrhosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Rehmanniae 4-30 part Fructus Lycii 4-30 part Ganoderma 2-15 part
Carapax Trionycis (processed) 4-30 part Radix Notoginseng 3-20 part Radix Angelicae Sinensis 4-30 part
Cortex Moutan 3-20 part
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Medical practice proves, liver cirrhosis patient is many because of the chronic hepatitis protracted course of disease, shows effect repeatedly and causes widely hepatic necrosis, large tracts of land hepatic fibrosis and cause that wherein hypoimmunity is crucial one-tenth cause of disease element.So the body resistance strengthening and constitution consolidating, enhancing human body immunity power should be the key link of treatment liver cirrhosis.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood are intended to enhancing human body immunity power in the side; Radix Rehmanniae, Fructus Lycii, the nourishing the liver of Carapax Trionycis (processed) nourishing YIN, the nourishing kidney of enriching blood; Cortex Moutan, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the merit of blood circulation promoting and blood stasis dispelling, nourishing YIN nourishing the liver, blood stasis dispelling removing food stagnancy, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Rehmanniae 50 gram Fructus Lyciis 50 kairine sesames 30 grams
Carapax Trionycis (processed) 50 gram Radix Notoginseng 40 gram Radix Angelicae Sinensis 50 grams
Cortex Moutan 40 grams
Weight in accordance with regulations, with conventional water extraction process Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted, make extractum fine powder 72 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Rehmanniae 180 gram Fructus Lyciis 180 kairine sesames 90 grams
Carapax Trionycis (processed) 200 gram Radix Notoginseng 120 gram Radix Angelicae Sinensis 120 grams
Cortex Moutan 120 grams
By above-mentioned same method, make 1607 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Rehmanniae 250 gram Fructus Lyciis 300 kairine sesames 130 grams
Carapax Trionycis (processed) 300 gram Radix Notoginseng 180 gram Radix Angelicae Sinensis 250 grams
Cortex Moutan 180 grams
By above-mentioned same method, make 2478 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
2 parts of 4 portions of Ganodermas of 5 portions of Fructus Lyciis of Radix Rehmanniae
5 parts of 3 parts of Radix Angelicae Sinensis of 5 portions of Radix Notoginseng of Carapax Trionycis (processed)
3 parts of Cortex Moutans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 20 portions of Ganodermas of 20 portions of Fructus Lyciis of Radix Rehmanniae
20 parts of 15 parts of Radix Angelicae Sinensis of 25 portions of Radix Notoginseng of Carapax Trionycis (processed)
15 parts of Cortex Moutans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 14 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially; Jaundice, anemia or bleeding tendency is arranged; Liver palm, spider angioma, cutaneous pigmentation and edema etc. appear.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 8 examples do not have other serious disease, and the age is 51 years old-76 years old, 66.2 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears; Hepatic fibrosis inspection index is obviously alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 6 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.14 philtrums of clinical experiment, produce effects 7 people, effective 6 people, invalid 1 people, total effective rate 92.8%.

Claims (1)

1. a Chinese medicine for the treatment of liver cirrhosis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Rehmanniae 4---15 parts of 30 portions of Fructus Lyciis 4---30 portions of Ganodermas 2---
Carapax Trionycis (processed) 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---
Cortex Moutan 3---20 parts
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
CN2009102361821A 2009-10-22 2009-10-22 Chinese medicament for treating liver cirrhosis Expired - Fee Related CN101843773B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102361821A CN101843773B (en) 2009-10-22 2009-10-22 Chinese medicament for treating liver cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102361821A CN101843773B (en) 2009-10-22 2009-10-22 Chinese medicament for treating liver cirrhosis

Publications (2)

Publication Number Publication Date
CN101843773A CN101843773A (en) 2010-09-29
CN101843773B true CN101843773B (en) 2011-09-28

Family

ID=42768711

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102361821A Expired - Fee Related CN101843773B (en) 2009-10-22 2009-10-22 Chinese medicament for treating liver cirrhosis

Country Status (1)

Country Link
CN (1) CN101843773B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101953893A (en) * 2010-10-14 2011-01-26 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis
CN101972307A (en) * 2010-10-21 2011-02-16 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating liver cirrhosis
CN101966306A (en) * 2010-10-27 2011-02-09 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating liver cirrhosis
CN101966230A (en) * 2010-11-04 2011-02-09 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis
CN101991652A (en) * 2010-11-11 2011-03-30 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating liver cirrhosis
CN102138983A (en) * 2010-11-18 2011-08-03 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating hepatocirrhosis
CN102091130A (en) * 2010-11-25 2011-06-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating liver cirrhosis
CN102114080A (en) * 2010-12-13 2011-07-06 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis
CN102172369A (en) * 2010-12-20 2011-09-07 北京绿源求证科技发展有限责任公司 Chinese medicine for treating hepatocirrhosis
CN102048831A (en) * 2010-12-24 2011-05-11 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis

Also Published As

Publication number Publication date
CN101843773A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843773B (en) Chinese medicament for treating liver cirrhosis
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN102172369A (en) Chinese medicine for treating hepatocirrhosis
CN101843766B (en) Chinese medicament for treating psoriasis
CN101843877B (en) Chinese medicament for treating liver cirrhosis
CN101843703B (en) Chinese medicament for treating liver cirrhosis
CN101843777B (en) Chinese medicament for treating liver cirrhosis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101874865B (en) Traditional Chinese medicine for treating cirrhosis
CN101953893A (en) Traditional Chinese medicine for treating cirrhosis
CN101843726B (en) Chinese medicament for treating chronic hepatitis
CN101843879B (en) Chinese medicament for treating liver cirrhosis
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN102068569A (en) Traditional Chinese medicine for treating cirrhosis
CN102114080A (en) Traditional Chinese medicine for treating cirrhosis
CN101843721B (en) Chinese medicament for treating psoriasis
CN101884762B (en) Traditional Chinese medicine for treating emphysema
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101843817B (en) Chinese medicament for treating chronic hepatitis
CN101843702B (en) Chinese medicament for treating psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: LIU XINZHUANG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150805

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150805

Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102

Patentee after: Liu Xinzhuang

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110928

CF01 Termination of patent right due to non-payment of annual fee